Browsing by Author van Zandwijk, Nico

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 47 < previous   next >
Issue DateTitleAuthor(s)Citation
2012Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural MesotheliomaCheng, Victoria (Yuen); Edelman, John (James); Kao, Steven; Kirschner, Michaela; McCaughan, Brian; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Armstrong, Nicola; Badrian, Bahareh; Creaney, Jenette; Klebe, Sonja; Musk, A. W.; Mutsaers, Steven; Robinson, Bruce W.S.; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteIncreased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma, Journal of Thoracic Oncology, vol.7, 7, 2012,pp 1184-1191
2009Individualization of treatment in non-small cell lung cancervan Zandwijk, Nico; Concord Clinical School: ANZAC Research InstituteIndividualization of treatment in non-small cell lung cancer, F1000 Medicine Reports, vol.2009, 1:24,pp N/A-N/A
2016KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesotheliomaCheng, Victoria Yuen Yee; Edelman, John (James); Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Williams, Marissa; Kirschner, Michaela B; Klebe, Sonja; Leshchynska, Iryna; Lin, Ruby C. Y.; McCaughan, Brian; Sarun, Kadir; Sytnyk, Vladimir; Wright, Casey; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Asbestos Disease Research InstituteKCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma, Molecular Cancer, vol.15, 1, 2016,pp 1-12
2016KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesotheliomaCheng, Victoria Yuen Yee; Edelman, John (James); Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Williams, Marissa; Kirschner, Michaela B; Klebe, Sonja; Leshchynska, Iryna; Lin, Ruby C. Y.; McCaughan, Brian; Sarun, Kadir; Sytnyk, Vladimir; Wright, Casey; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Asbestos Disease Research InstituteKCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma, Molecular Cancer, vol.15, 1, 2016,pp 1-12
2013Long Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM)Cheng, Yuen (Dennis); Kirschner, Michaela; Reid, Glen; van Zandwijk, Nico; Wright, Casey; Schelch, Karin; Gray, Steven; Hoda, Mir; Klebe, Sonja; McCaughan, Brian; O’Byrne, Kenneth; Chemistry; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; School of Medical Sciences: Biomedical SciencesLong Non Coding RNAs (lncRNAs) Are Dysregulated in Malignant Pleural Mesothelioma (MPM), PLoS One, vol.8, 8, 2013,pp 1-12
2011Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural PneumonectomyChatfield, Mark; Clarke, Stephen; Kao, Steven; McCaughan, Brian; Reid, Glen; van Zandwijk, Nico; Vardy, Janette; Armstrong, Nicola; Henderson, Douglas W; Klebe, Sonja; Yan, Tristan; Clinical Schools; Northern Clinical School: Kolling Institute; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicineLow Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy, Journal of Thoracic Oncology, vol.6, 11, 2011,pp 1923-1929
2016Malignant mesothelioma in Australia 2015: Current incidence and asbestos exposure trendsLeigh, James; Soeberg, Matthew; van Zandwijk, Nico; School of Public Health: Public Health; School of Public Health: Public Health; Concord Clinical School: ANZAC Research InstituteMalignant mesothelioma in Australia 2015: Current incidence and asbestos exposure trends, Journal of Toxicology and Environmental Health. Part B: Critical Reviews, vol.19, 5-6, 2016,pp 173-189
2017Management of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studiesvan Zandwijk, Nico; Brustugun, O T; Buergy, D; Crino, L; Dingemans, Anne-Marie; Dusmet, Michael; Fennell, Dean; Giordano, F A; Gray, Jhanelle; Grunenwald, Dominique; Henzler, T; Huber, Rudolf Maria; Kostrzewa, M; Manegold, Christian; Meyer, M; Moniuszko, Marcin; Mornex, Francoise; Papotti, M; Perol, Maurice; Pilz, Lothar; Rathmann, N; Roessner, Eric Dominic; Schabel, Christoph; Senan, Suresh; Syrigos, K; van Meerbeeck, Jan; Vliegenthart, R; Voigt, Weiland; Zhou, Caicun; Concord Clinical School: MedicineManagement of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studies, Journal of Thoracic Oncology, vol.12, 12, 2017,pp 1755-1765
2016MicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patientsCheng, Victoria Yuen Yee; Reid, Glen; van Zandwijk, Nico; Kirschner, Michaela B; Lin, Ruby; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteMicroRNA gene expression signatures in long-surviving malignant pleural mesothelioma patients, Genomics Data, vol.9, N/A, 2016,pp 44-49
2015miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaCooper, Wendy Anne; Edelman, John (James); Hanh, Jacky; Kao, Steven; Kirschner, Michaela; Linton, Anthony; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Amaro-Mugridge, Nancy; Brahmbhatt, Himanshu; Cheng, YuenYee; Klebe, Sonja; Lin, Ruby C. Y.; MacDiarmid, Jennifer; McCaughan, Brian; Weiss, Jocelyn; Williams, Marissa; Wright, Casey; Central Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstitutemiR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma, Oncotarget, vol.6, 27, 2015,pp 23480-23495
2015MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesotheliomaArmstrong, Nicola Joy; Cheng, Yuen Yee; Kao, Steven; Kirschner, Michaela; Lin, Ruby; Linton, Anthony; McCaughan, Brian; Reid, Glen; van Zandwijk, Nico; Klebe, Sonja; Mathematics & Statistics; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Molecular Bioscience; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteMiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma, Molecular Oncology, vol.9, N/A, 2015,pp 715-726
2015Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC)van Zandwijk, Nico; Kumarakulasinghe, Nesaretnam; Soo, R. A.; Concord Clinical School: ANZAC Research InstituteMolecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC), Respirology, vol.20, 3, 2015,pp 370-378
2016Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972-2009Soeberg, Matthew; van Zandwijk, Nico; Young, Jane; Creighton, Nicola; Currow, David; School of Public Health: Public Health; Concord Clinical School: ANZAC Research Institute; School of Public Health: Public HealthPatterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972-2009, Australian and New Zealand Journal of Public Health, vol.40, 3, 2016,pp 255-262
2016Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972-2009Soeberg, Matthew; van Zandwijk, Nico; Young, Jane; Creighton, Nicola; Currow, David; School of Public Health: Public Health; Concord Clinical School: ANZAC Research Institute; School of Public Health: Public HealthPatterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972-2009, Australian and New Zealand Journal of Public Health, vol.40, 3, 2016,pp 255-262
2013Patterns of care for malignant pleural mesothelioma patients compensated by the Dust Diseases Board in New South Wales, AustraliaClarke, Stephen; Kao, Steven; van Zandwijk, Nico; Vardy, Janette; Clarke, Christopher Clarke; Corte, Peter; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Concord Clinical School: MedicinePatterns of care for malignant pleural mesothelioma patients compensated by the Dust Diseases Board in New South Wales, Australia, Internal Medicine Journal, vol.43, 4, 2013,pp 402-410
2012A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancervan Zandwijk, Nico; Au, J; Benner, R; Blasinska-Morawiec, M; et al, various; Jassem, J; Krzakowski, Maciej; Manegold, Christian; Serwatowski, P; Szczesna, A.; Tan, E; Zatloukal, P; Concord Clinical School: ANZAC Research InstituteA phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer, Annals of Oncology, vol.23, 1, 2012,pp 72-77
2017The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLCvan Zandwijk, Nico; Brustugun, Odd Terje; Dingemans, Anne-Marie; et al, Various; Grey, Jhanelle; Manegold, C; Nakagawa, Kazuhiko; Nicolson, Marianne; Peters, Solange; Reck, Martin; Wu, Yi-long; Concord Clinical School: MedicineThe Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC, Journal of Thoracic Oncology, vol.12, 2, 2017,pp 194-207
2016A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesotheliomaClarke, Stephen; Cooper, Wendy Anne; Kao, Steven; McCaughan, Brian; Pavlakis, Nick; Reid, Glen; Vallely, Michael; van Zandwijk, Nico; Burgers, Sjaak A; Edelman, James B; Kirschner, Michaela B; Korse, Tiny; Molloy, Mark P; Tran, Thang N.; van den Broek, Daan; Wright, Casey; Northern Clinical School: Kolling Institute; Central Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Northern Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: ANZAC Research InstituteA proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesothelioma, British Journal of Cancer, vol.114, 5, 2016,pp 524-531
2009Reply to L.H. de Lima Araujo et alvan Zandwijk, Nico; Groen, Harry J M; Smit, Egbert F.; Concord Clinical School: ANZAC Research InstituteReply to L.H. de Lima Araujo et al, Journal of Clinical Oncology, vol.28, 2,pp e26-e26
2014An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesotheliomaCheng, Yuen Yee; Gattani, S; Kao, Steven; Kirschner, Michaela; Linton, Anthony; McCaughan, Brian; Reid, Glen; Srikaran, Subothini; van Zandwijk, Nico; Griggs, Kim; Klebe, Sonja; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Concord Clinical School: Medicine; Concord Clinical School: Asbestos Disease Research Institute; Concord Clinical School: ANZAC Research InstituteAn RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma, British Journal of Cancer, vol.110, 2, 2014,pp 510-519